The deletion allele of angiotensin-converting enzyme gene polymorphism as a cardiovascular risk factor in patients undergoing long-term hemodialysis [8]

Annals of Internal Medicine

Volumn 133, Issue 11, 2000, Pages 924-

  Ishimitsu, T ^a   Hosoya, K ^a   Matsuoka, H ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELISM; CORONARY RISK; DELETION MUTANT; GENETIC POLYMORPHISM; GENOTYPE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; POPULATION RISK; PRIORITY JOURNAL; RISK FACTOR;

EID: 0034610357     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-133-11-200012050-00027     Document Type: Letter

References (5)

1. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
2. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease
3. Angiotensin-converting enzyme gene polymorphism and cardiovascular disease
4. Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease
5. Cardiovascular mortality and morbidity in dialysis patients